ロード中...
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) reactivation remains one of the most common and life-threatening infectious complications following allogeneic hematopoietic stem cell transplantation, despite novel diagnostic technologies, several novel prophylactic agents, and further improvements in preemptive therapy and t...
保存先:
| 出版年: | Blood |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7484743/ https://ncbi.nlm.nih.gov/pubmed/32202631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000956 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|